Gene Therapy Potency Assay Summit

Temi della conferenza
The Inaugural Gene Therapy Potency Summit (August 29-31) is dedicated to providing you with tools to identify, characterize and measure potency, enabling you to take tactical insights back to your team. The content will focus on the "sweet spot" of drug development where potency is most critical - pre-clinical development through to commercialization.

This is the only industry-led event dedicated to covering all challenges associated with potency for gene therapy drug developers specifically.

Scientific organizer
Hanson Wade

Annotazioni
Brochure: https://go.evvnt.com/1720286-0?pid=4832

Speakers: Pankaj Mandal, FDA, Cullen Mason, Biogen, Dorota Bulik, Ultragenyx Pharmaceutical, Ilya Shestopalov, bluebird bio, Isaac Hutchinson, Johnson and Johnson Services and More.

https://go.evvnt.com/1720286-2?pid=4832

Mr. Customer Services